Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

2.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

3.

Squeezing through tiny blood vessels may trigger melanoma cells to spread

4.

Fear of hair loss might cause some to reject cancer treatment

5.

Q&A: Why adolescents and young adults with cancer are falling behind


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot